Skip to content
Biodatica
Start free

Investigator

Aaron N Hata

MASSACHUSETTS GENERAL HOSPITAL · funded by NCI

Companies
1

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$810k

Summed across those awards.

First award
Mar 1, 2009

Latest Feb 20, 2012.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors

    $418k

    Feb 20, 2012NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11142598 (opens the source filing in a new tab)

  2. R01

    Non-genomic resistance mechanisms in EGFR-mutant lung cancer

    $392k

    Mar 1, 2009NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11093977 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources